Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...

Panelists discuss the role of molecular testing in metastatic non–-small cell lung cancer (NSCLC), emphasizing its importance in identifying actionable mutations and guiding personalized treatment ...

With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

(RTTNews) - BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company, on Monday announced the resolution of lung metastasis in the first patient treated with Bria-OTS, a ...

Therapeutics announces an unprecedented clinical response including resolution of a lung metastasis with stable disease ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ monotherapy No toxicity related to the treatment; Patient remains on study ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS ...